BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,532,396 | -30.7% | 2,758,813 | -31.1% | 0.06% | -32.1% |
Q2 2023 | $28,193,088 | +6218.6% | 4,004,700 | +7385.4% | 0.08% | +8300.0% |
Q1 2023 | $446,190 | -98.0% | 53,500 | -97.3% | 0.00% | -98.7% |
Q4 2022 | $22,829,438 | +235.0% | 1,988,627 | +208.7% | 0.08% | +169.0% |
Q2 2022 | $6,815,000 | +1847.1% | 644,100 | +2448.7% | 0.03% | +2800.0% |
Q4 2021 | $350,000 | -88.1% | 25,272 | -87.6% | 0.00% | -92.3% |
Q3 2021 | $2,930,000 | -87.8% | 203,913 | -93.7% | 0.01% | -88.9% |
Q4 2020 | $24,069,000 | +1007.6% | 3,230,800 | +410.7% | 0.12% | +963.6% |
Q3 2020 | $2,173,000 | -48.6% | 632,600 | -28.7% | 0.01% | -60.7% |
Q2 2020 | $4,229,000 | -29.9% | 887,570 | -70.6% | 0.03% | -42.9% |
Q1 2020 | $6,036,000 | -79.1% | 3,018,132 | -64.0% | 0.05% | -67.8% |
Q4 2019 | $28,921,000 | +209.6% | 8,382,900 | +157.1% | 0.15% | +166.7% |
Q3 2019 | $9,340,000 | +2319.7% | 3,260,000 | +6770.0% | 0.06% | +2750.0% |
Q1 2019 | $386,000 | -86.3% | 47,453 | -86.4% | 0.00% | -85.7% |
Q4 2018 | $2,825,000 | -38.4% | 350,000 | -62.5% | 0.01% | -30.0% |
Q4 2017 | $4,585,000 | +15183.3% | 933,766 | +46588.3% | 0.02% | – |
Q2 2015 | $30,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |